Latest Asx Listing Rules News

PEXA Group has dismissed any undisclosed information behind its recent share price drop, attributing market moves to a preliminary IPART pricing consultation paper.

CVC Limited has addressed ASX concerns over a delayed Appendix 3Y filing related to director John Leaver’s interest change, attributing the delay to administrative oversight while affirming existing compliance policies.

Korab Resources has progressed the sale of its Geolsec mineral lease ML27362 to Leka Fertiliser Shipping Pty Ltd for $4.35 million plus royalties, navigating buyer restructuring and pending ASX approval.

Kina Securities Limited has adjusted its FY25 net profit after tax downward by PGK6.1 million following auditor discussions, though the company’s cash flow and 2026 outlook remain unaffected.

Estrella Resources has inked an $8 million underwriting agreement with Million Link (China) Investment Ltd to support the exercise of 445 million listed options, aiming to strengthen its capital position ahead of the options’ December expiry.

Macarthur Minerals has successfully raised A$1.25 million through an oversubscribed placement, positioning the company to advance exploration and maintain tenements at its Lake Giles Iron Project.

Empire Resources has completed the second tranche of its share placement, raising nearly A$2 million following shareholder approval. This capital boost supports the company’s ongoing exploration ambitions in Western Australia’s gold and copper sectors.

Genetic Technologies Limited remains under voluntary administration with minimal cash outflows and $0.276 million in cash as it navigates its Deed of Company Arrangement.

MyEco Group launches a $2 million Series 2 convertible note offer targeting sophisticated investors, featuring a 10.5% annual interest and a 15% discount on share conversion prices.

Anax Metals Limited has successfully completed the first tranche of its capital raising, issuing 225.5 million shares to institutional and sophisticated investors and securing $5.2 million in fresh funds.

Thrive Tribe Technologies has completed a $240,554 capital raise through a discounted share placement, aiming to bolster its working capital. The placement involved issuing over 318 million shares at a 25% discount, with Clee Capital acting as lead manager.

Atomo Diagnostics has responded to an ASX price query following unusual trading activity, denying any undisclosed price-sensitive information while acknowledging a related FDA update involving Lumos Diagnostics.